论文部分内容阅读
目的评价立体定向射频消融(SRFA)治疗结直肠肝转移瘤(CRLM)的疗效。方法经伦理委员会批准,回顾性评估连续的63例病人189个CRLM的98次射频消融治疗过程。分析局部复发率(LR)、总体生存期(OS)和无病生存期(DFS)。结果LR见于16%(31/189)的肿瘤,瘤体直径为<3cm
Objective To evaluate the efficacy of stereotactic radiofrequency ablation (SRFA) in the treatment of colorectal liver metastases (CRLM). METHODS: With the approval of the ethics committee, 98 radiofrequency ablation procedures for 189 CRLMs in 63 consecutive patients were retrospectively evaluated. Local recurrence rate (LR), overall survival (OS), and disease-free survival (DFS) were analyzed. Results LR was seen in 16% (31/189) of tumors with a tumor diameter of <3cm